Best.Energy, the business energy monitoring and management company, announces an exciting growth stage in 2022, as it looks to expand its energy efficiency operations in the UK. With most businesses wasting between 10-40% of their energy spend and the energy price cap set to rise by 54% in April 2022, energy efficiency and management has… Read More »
BALTIMORE, July 1, 2021 /PRNewswire/ –Lupin Pharmaceuticals, Inc., the U.S. based wholly-owned subsidiary of global pharma major Lupin Limited (Lupin), announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s supplemental New Drug Application (sNDA) to expand the use of Solosec (secnidazole) to include the treatment of trichomoniasis in adults. Trichomoniasis… Read More »
BOSTON–(BUSINESS WIRE)–Jun. 9, 2021– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved expanded use of Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to include children with cystic fibrosis (CF) ages 6 through 11 years who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene or a… Read More »
London, UK, Oslo, Norway and New York, NY, 7th January 2021 – Confirmit, a leading provider of solutions that enable Market Research, Customer Experience and Employee Engagement teams to turn insights into stories that fuel action, announced today its intention to merge with FocusVision, a leading provider of customer insights technology. The merger is conditioned… Read More »